Fig. 1From: Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohortChange in patients’ demographics and treatment from 2012 to 2021. A Box plots showing the change in the mean patient age. B Change in the proportion of age groups. C Percentage of patients treated with MTX, GCs, and b/tsDMARDsBack to article page